Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment.
As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology.
Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer.
Vice President, Preclinical & Translational Research, HOOKIPA Pharma Inc.
Assistant Professor, Cancer Immunology, University of Southampton, UK
Head, Oncology Bioinformatics, Merck Healthcare, Germany
T-Cell Immunotherapy, Group Leader, University College London
Scientific Founder and Chief Scientific Officer, Leucid Bio
Professor, Translational Cancer Immunology and Immunotherapy, Kings College London, UK
Group Lead, ETH Zürich
Professor, Cancer Immunotherapy, University of Nottingham, UK
CSO, ViroCell Biologics Ltd
CEO, Celyad Oncology
Vice President, Translational Biology, Crescendo Biologics
Professor, Immunology and Immunotherapy, University of Southampton
Global Pricing & Market Access Director, Oncology Diagnostics,, AstraZeneca
Senior Project Manager Immune Oncology, Evaxion Biotech
CSO , JJP Biologics
Associate Director, Business Development, Veracyte
Director, Strategy Business Development, Sanyou Biopharmaceuticals
Senior Representative Canopy Biosciences,
Senior Representative ANGLE plc,
Chief Business Officer, Secarna Pharmaceuticals